Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharma
Inside the ICE House
•
21m
AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.
Up Next in Inside the ICE House
-
Alto Neuroscience CEO Dr. Amit Etkin ...
The future of mental health is being transformed, moving beyond trial-and-error treatments to science-driven precision. Breakthroughs in neuroscience, AI, and precision medicine are mapping the brain’s unique biological signatures, creating pathways for personalized care. Alto Neuroscience is at ...
-
New York Giants' Kayvon Thibodeaux on...
New York Giants linebacker Kayvon Thibodeaux goes Inside the ICE House to discuss his NIL tour and efforts to help student-athletes navigate money, opportunities and life beyond sports. He shares lessons from his own experience, emphasizing financial literacy, leadership and the importance of lon...
-
Outgoing Missouri Gov. Mike Parson Pl...
As a third-generation farmer, Mike Parson, the 57th Governor of Missouri, has a deep empathy for the challenges and opportunities facing farmers in the Show-Me State's agricultural community. As his time in office winds down and a return to the seat of his John Deere tractor draws near, Gov. Pars...
